USD 3.9
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.11 Million USD | -18.45% |
2022 | -1.93 Million USD | -65.13% |
2021 | 5.12 Million USD | -22.4% |
2020 | 5.18 Million USD | 0.0% |
2019 | 8.9 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 477 Thousand USD | 226.46% |
2024 Q1 | 223 Thousand USD | -67.06% |
2023 Q4 | 964 Thousand USD | 269.35% |
2023 FY | - USD | -18.45% |
2023 Q3 | 261 Thousand USD | -62.5% |
2023 Q2 | 696 Thousand USD | 186.78% |
2023 Q1 | -802 Thousand USD | -269.92% |
2022 FY | - USD | -65.13% |
2022 Q4 | 472 Thousand USD | 0.0% |
2021 FY | - USD | -22.4% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Healwell AI Inc. | -16.11 Million USD | 106.938% |